Overview
The Balance Study is evaluating the safety and efficacy of an investigational drug for bipolar I depression in children and adolescents aged 10 to 17 years. The study will enroll about 380 children and adolescents at participating study centers throughout North America. No cost to participate; all study-related visits, tests, and investigational drug are provided at no cost.
